デフォルト表紙
市場調査レポート
商品コード
1472083

免疫診断の世界市場規模調査&予測、製品別、用途別、エンドユーザー別、地域別分析、2023年~2030年

Global Immunodiagnostics Market Size Study & Forecast, by Product, By Application, By End user, and Regional Analysis, 2023-2030


出版日
ページ情報
英文 200 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
免疫診断の世界市場規模調査&予測、製品別、用途別、エンドユーザー別、地域別分析、2023年~2030年
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫診断の世界市場は、2022年にはおよそ178億3,000万米ドルと評価され、予測期間2023年~2030年には7.30%以上の成長率で成長すると予測されています。

免疫診断学は、病気や感染を検出するために免疫系の反応を利用する診断学の一分野です。病気を正確に診断するために、抗体、抗原、サイトカインなど免疫系の特定の成分を測定する様々な技術が用いられます。免疫診断学は、様々な病態における疾患の検出とモニタリングのための正確で高感度かつ迅速な方法を提供することにより、診断学の分野に革命をもたらしました。さらに、感染症の流行増加、高齢者人口の増加、個別化医療に対する認識と需要の高まりは、予測期間2023-2030年の間に市場に有利な需要を生み出すと予想されます。

その他の特典として、患者やヘルスケア専門家の間で、正確な診断検査によって個々の患者の特性に合わせて治療法を調整する個別化医療の利点に対する認識が高まっています。免疫診断は、個別化医療のアプローチを促進する上で重要な役割を果たしています。したがって、個別化医療に対する需要の高まりが市場の成長を支えるものと予想されます。Statistaによると、2019年の個別化医療市場は1兆9,800億米ドルと評価され、2022年には2兆7,700億米ドルに達すると予測されています。さらに、医療費の増加、政府の支援策や資金援助は、市場成長に有利な機会を生み出すと予測されています。しかし、免疫診断製品の高コストと厳しい政府規制が、2023年~2030年の予測期間を通じて市場成長を阻害しています。

免疫診断の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、医療費の増加、免疫診断技術の継続的な進歩、主要市場プレイヤーの存在、予防医療に対する意識の高まりと注目により、2022年に最大の市場シェアを獲得し、市場を独占しました。一方、アジア太平洋地域は、がん、糖尿病、自己免疫疾患、HIV/AIDSのような感染症のような慢性疾患の罹患率の上昇、高齢化人口の増加、支持的な規制環境、大手製薬企業やバイオテクノロジー企業の存在、学術研究機関、免疫診断の研究開発活動を支援する政府のイニシアチブなどの要因により、予測期間中に最も速い成長率で成長すると予想されます。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 免疫診断の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 免疫診断の世界市場力学

  • 免疫診断市場の影響分析(2020年~2030年)
    • 市場促進要因
      • 感染症の流行増加
      • 高齢者人口の増加
      • 個別化医療に対する認識と需要の高まり
    • 市場の課題
      • 免疫診断製品の高コスト
      • 厳しい政府規制
    • 市場機会
      • ヘルスケア支出の増加
      • 政府の支援策と資金援助

第4章 免疫診断の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 免疫診断の世界市場:製品別

  • 市場スナップショット
  • 免疫診断の世界市場:製品別、実績 - ポテンシャル分析
  • 免疫診断の世界市場:製品別推定・予測2020年~2030年
  • 免疫診断市場、サブセグメント別分析
    • 機器
    • 試薬・消耗品

第6章 免疫診断の世界市場:用途別

  • 市場スナップショット
  • 免疫診断の世界市場:用途別、実績 - ポテンシャル分析
  • 免疫診断の世界市場:用途別推定・予測2020年~2030年
  • 免疫診断市場、サブセグメント分析
    • 腫瘍学・内分泌学
    • 肝炎・レトロウイルス
    • 心臓マーカー
    • 感染症
    • その他

第7章 免疫診断市場:エンドユーザー別

  • 市場スナップショット
  • 免疫診断の世界市場:エンドユーザー別、実績 - ポテンシャル分析
  • 免疫診断の世界市場:エンドユーザー別推定・予測2020~2030年
  • 免疫診断市場、サブセグメント分析
    • 臨床検査機関
    • 病院
    • 医院
    • その他

第8章 免疫診断の世界市場:地域別分析

  • 主要国
  • 主な新興国
  • 免疫診断市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品の推定・予測、2020年~2030年
      • 用途の推定・予測、2020年~2030年
      • エンドユーザーの推定・予測、2020年~2030年
    • カナダ
  • 欧州の免疫診断市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の免疫診断市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの免疫診断市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Sysmex Corporation
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
      • 最近の動向
    • Arkray, Inc.
    • Danaher Corporation(Beckman Coulter)
    • Siemens AG
    • Immunodiagnostic Systems Holdings Plc
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Diasorin S.P.A.
    • Johnson & Johnson Services, Inc

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Immunodiagnostics Market, report scope
  • TABLE 2.Global Immunodiagnostics Market estimates & forecasts by region 2020-2030 (USD Billion)
  • TABLE 3.Global Immunodiagnostics Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4.Global Immunodiagnostics Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5.Global Immunodiagnostics Market estimates & forecasts by End user 2020-2030 (USD Billion)
  • TABLE 6.Global Immunodiagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Immunodiagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Immunodiagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Immunodiagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Immunodiagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Immunodiagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Immunodiagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Immunodiagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Immunodiagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Immunodiagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.U.S. Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.Canada Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20.Canada Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.Canada Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.UK Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23.UK Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.UK Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.Germany Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26.Germany Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.Germany Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.France Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29.France Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.France Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.Italy Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32.Italy Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Italy Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Spain Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35.Spain Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.Spain Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.RoE Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38.RoE Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.RoE Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.China Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41.China Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.China Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.India Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44.India Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.India Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.Japan Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47.Japan Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.Japan Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.South Korea Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50.South Korea Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.South Korea Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.Australia Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53.Australia Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.Australia Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.Brazil Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59.Brazil Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Brazil Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Mexico Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62.Mexico Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.Mexico Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.RoLA Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65.RoLA Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.RoLA Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.Saudi Arabia Immunodiagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68.South Africa Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.RoMEA Immunodiagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70.List of secondary sources, used in the study of global Immunodiagnostics Market
  • TABLE 71.List of primary sources, used in the study of global Immunodiagnostics Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Immunodiagnostics Market, research methodology
  • FIG 2.Global Immunodiagnostics Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Immunodiagnostics Market, key trends 2022
  • FIG 5.Global Immunodiagnostics Market, growth prospects 2023-2030
  • FIG 6.Global Immunodiagnostics Market, porters 5 force model
  • FIG 7.Global Immunodiagnostics Market, pest analysis
  • FIG 8.Global Immunodiagnostics Market, value chain analysis
  • FIG 9.Global Immunodiagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Immunodiagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Immunodiagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Immunodiagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Immunodiagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Immunodiagnostics Market, regional snapshot 2020 & 2030
  • FIG 15.North America Immunodiagnostics Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Immunodiagnostics Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia pacific Immunodiagnostics Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Immunodiagnostics Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Immunodiagnostics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics is a branch of diagnostics that utilizes the immune system's response to detect diseases or infections. It involves the use of various techniques to measure specific components of the immune system, such as antibodies, antigens, or cytokines, in order to diagnose diseases accurately. The immunodiagnostics has revolutionized the field of diagnostics by providing accurate, sensitive, and rapid methods for disease detection and monitoring across a wide range of medical conditions. Moreover, the rising prevalence of infectious diseases, growing geriatric population, increasing awareness and demand for personalized medicine are anticipated to create the lucrative demand for the market during forecast period 2023-2030.

Additionally, growing awareness among patients and healthcare professionals about the benefits of personalized medicine, which relies on precise diagnostic tests to tailor treatments according to individual patient characteristics. Immunodiagnostics plays a crucial role in facilitating personalized medicine approaches. Thus, the growing demand for the personalized medicines is anticipated to support the market growth. According to Statista, in 2019, the personalized medicine market was valued USD 1980 billion and it is anticipated to reach USD 2770 billion in 2022. Moreover, the rising healthcare expenditure, and supportive government initiatives and funding are anticipated to create the lucrative opportunity for the market growth. However, the high cost of immunodiagnostic products and stringent government regulations stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Immunodiagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the increasing healthcare expenditure, continuous advancement in immunodiagnostic technologies, presence of key market players, and rising awareness and focus on preventive healthcare. Whereas, the Asia Pacific region is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the rising incidence of chronic diseases such as cancer, diabetes, autoimmune disorders, and infectious diseases like HIV/AIDS, growing aging population, supportive regulatory environment, presence of leading pharmaceutical and biotechnology companies, academic research institutions, and government initiatives supporting research and development activities in immunodiagnostics.

Major market players included in this report are:

  • Sysmex Corporation
  • Arkray, Inc.
  • Danaher Corporation (Beckman Coulter)
  • Siemens AG
  • Immunodiagnostic Systems Holdings Plc
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Diasorin S.P.A.
  • Johnson & Johnson Services, Inc.

Recent Developments in the Market:

  • In August 2022, Bio-Rad Laboratories acquired the shares of Curiosity Diagnostics. Curiosity Diagnostics is a Warsaw, Poland-based developer of innovative technology solutions catering to several markets of healthcare and medical diagnostics.

Global Immunodiagnostics Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, End user, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Instruments
  • Reagents & Consumables

By Application:

  • Oncology & Endocrinology
  • Hepatitis & Retrovirus
  • Cardiac Markers
  • Infectious Diseases
  • Others

By End user:

  • Clinical Laboratories
  • Hospitals
  • Physician's Offices
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Immunodiagnostics Market, by region, 2020-2030 (USD Billion)
    • 1.2.2.Immunodiagnostics Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3.Immunodiagnostics Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4.Immunodiagnostics Market, by End user, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Immunodiagnostics Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Immunodiagnostics Market Dynamics

  • 3.1.Immunodiagnostics Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Rising prevalence of infectious diseases
      • 3.1.1.2.Growing geriatric population
      • 3.1.1.3.Increasing awareness and demand for personalized medicine
    • 3.1.2.Market Challenges
      • 3.1.2.1.High cost of immunodiagnostic products
      • 3.1.2.2.Stringent government regulations
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Rising healthcare expenditure
      • 3.1.3.2.Supportive government initiatives and fundings

Chapter 4.Global Immunodiagnostics Market: Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economic
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Immunodiagnostics Market, by Product

  • 5.1.Market Snapshot
  • 5.2.Global Immunodiagnostics Market by Product, Performance - Potential Analysis
  • 5.3.Global Immunodiagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4.Immunodiagnostics Market, Sub Segment Analysis
    • 5.4.1.Instruments
    • 5.4.2.Reagents & Consumables

Chapter 6.Global Immunodiagnostics Market, by Application

  • 6.1.Market Snapshot
  • 6.2.Global Immunodiagnostics Market by Application, Performance - Potential Analysis
  • 6.3.Global Immunodiagnostics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4.Immunodiagnostics Market, Sub Segment Analysis
    • 6.4.1.Oncology & Endocrinology
    • 6.4.2.Hepatitis & Retrovirus
    • 6.4.3.Cardiac Markers
    • 6.4.4.Infectious Diseases
    • 6.4.5.Others

Chapter 7.Immunodiagnostics Market, by End user

  • 7.1.Market Snapshot
  • 7.2.Global Immunodiagnostics Market by End user, Performance - Potential Analysis
  • 7.3.Global Immunodiagnostics Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
  • 7.4.Immunodiagnostics Market, Sub Segment Analysis
    • 7.4.1.Clinical Laboratories
    • 7.4.2.Hospitals
    • 7.4.3.Physician's Offices
    • 7.4.4.Others

Chapter 8.Global Immunodiagnostics Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Immunodiagnostics Market, Regional Market Snapshot
  • 8.4.North America Immunodiagnostics Market
    • 8.4.1.U.S. Immunodiagnostics Market
      • 8.4.1.1.Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.End user breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Immunodiagnostics Market
  • 8.5.Europe Immunodiagnostics Market Snapshot
    • 8.5.1.U.K. Immunodiagnostics Market
    • 8.5.2.Germany Immunodiagnostics Market
    • 8.5.3.France Immunodiagnostics Market
    • 8.5.4.Spain Immunodiagnostics Market
    • 8.5.5.Italy Immunodiagnostics Market
    • 8.5.6.Rest of Europe Immunodiagnostics Market
  • 8.6.Asia-Pacific Immunodiagnostics Market Snapshot
    • 8.6.1.China Immunodiagnostics Market
    • 8.6.2.India Immunodiagnostics Market
    • 8.6.3.Japan Immunodiagnostics Market
    • 8.6.4.Australia Immunodiagnostics Market
    • 8.6.5.South Korea Immunodiagnostics Market
    • 8.6.6.Rest of Asia Pacific Immunodiagnostics Market
  • 8.7.Latin America Immunodiagnostics Market Snapshot
    • 8.7.1.Brazil Immunodiagnostics Market
    • 8.7.2.Mexico Immunodiagnostics Market
  • 8.8.Middle East & Africa Immunodiagnostics Market
    • 8.8.1.Saudi Arabia Immunodiagnostics Market
    • 8.8.2.South Africa Immunodiagnostics Market
    • 8.8.3.Rest of Middle East & Africa Immunodiagnostics Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1.Sysmex Corporation
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2.Arkray, Inc.
    • 9.3.3.Danaher Corporation (Beckman Coulter)
    • 9.3.4.Siemens AG
    • 9.3.5.Immunodiagnostic Systems Holdings Plc
    • 9.3.6.Thermo Fisher Scientific, Inc.
    • 9.3.7.F. Hoffmann-La Roche Ltd.
    • 9.3.8.Abbott Laboratories
    • 9.3.9.Diasorin S.P.A.
    • 9.3.10.Johnson & Johnson Services, Inc

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption